Hepatitis C
243 results
1 - 100
Hepatitis C
Hepatitis C- MICROBIOLOGY
- CLINICAL
- SITES OF INFECTION
- TREATMENT
- General comments
- Treatment-naive
- Treatment failures
- HIV/HCV co-infection
- Cirrhotic patients
- Chronic kidney disease patients
- Regimens NOT recommended
- Follow-up
- Experimental and Future HCV Treatment Options
- Prevention
- OTHER INFORMATION
- Basis for recommendation
- References
- Hepatitis Due to Infections other than Hepatitis A, B, C, D, or E
- Ribavirin
- Daclatasvir
- Interferon alfa
- Hepatitis B (HBV) vaccines
- Hepatitis B (HBV) vaccines
- Interferon alpha (ABX)
- Hepatitis A
- Hepatitis A vaccine (HAV)
- Hepatitis A vaccine (HAV)
- Sofosbuvir + velpatasvir
- Sofosbuvir + velpatasvir
- Staging Liver Disease
- Tipranavir
- Tipranavir
Kelly Gebo, M.D.- Hepatitis D
- Sofosbuvir
- Sofosbuvir
- Elbasvir/Grazoprevir
- Elbasvir/Grazoprevir
- Ribavirin
- Hepatitis B
- Retroviral Syndrome, Acute
- Retroviral Syndrome, Acute
- Technivie
- Mark Sulkowski, M.D.
- Telithromycin
- Myocarditis
- HIV Solid Organ Transplant Candidate/Recipient
- Simeprevir
- Simeprevir
- Ticarcillin
- Piperacillin
- COVID-19 Convalescent Plasma
- COVID-19 Convalescent Plasma
- Candidiasis, vulvovaginal
- Ticarcillin + Clavulanic Acid
- Sofosbuvir + Ledipasvir
- Sofosbuvir + Ledipasvir
- HIV, Occupational Exposure
- HIV, Occupational Exposure
- Hep B-Hyperimmune globulin
- Myelitis
- Flucloxacillin